Phase I/II trial of association of sorafenib in combination with temozolomide in patients with metastatic melanoma: Looking for predictive markers of efficacy

C. Robert, N. Chaput, N. Lassau, A. Auperin, S. Koscielny, E. Hollville, V. Lazar, L. Lacroix, J. Soria, C. Mateus

Research output: Contribution to journal › Abstract

Fingerprint

Dive into the research topics of 'Phase I/II trial of association of sorafenib in combination with temozolomide in patients with metastatic melanoma: Looking for predictive markers of efficacy'. Together they form a unique fingerprint.

Medicine & Life Sciences